Clinical trial
Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
NCT00638898 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
- Lead sponsor
- City of Hope Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 26, 2007
- Completion date
- December 10, 2024
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adult central nervous system germ cell tumor, adult rhabdomyosarcoma, childhood central nervous system germ cell tumor, childhood soft tissue sarcoma, ewing sarcoma, metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor, ovarian mixed germ cell tumor, previously untreated childhood rhabdomyosarcoma, recurrent adult brain tumor, recurrent adult soft tissue sarcoma, recurrent childhood brain stem glioma, recurrent childhood cerebellar astrocytoma, recurrent childhood cerebral astrocytoma, recurrent childhood ependymoma, recurrent childhood malignant germ cell tumor, recurrent childhood medulloblastoma, recurrent childhood pineoblastoma, recurrent childhood supratentorial primitive neuroectodermal tumor, recurrent childhood visual pathway and hypothalamic glioma, recurrent childhood visual pathway glioma, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent extragonadal germ cell tumor, recurrent extragonadal non-seminomatous germ cell tumor, recurrent malignant testicular germ cell tumor, recurrent neuroblastoma, recurrent ovarian germ cell tumor, recurrent wilms tumor and other childhood kidney tumors, solid tumor, unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific